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Abstract
Heterochromatic regions of eukaryotic genomes contain multiple functional elements involved in chromosomal dynamics,
as well as multiple housekeeping genes. Cytological and molecular peculiarities of heterochromatic loci complicate genetic
studies based on standard approaches developed using euchromatic genes. Here, we report the development of an RNAi-
based knockdown transgenic construct and red fluorescent reporter transgene for a small gene, Tim17b, which localizes in
constitutive heterochromatin of Drosophila melanogaster third chromosome and encodes a mitochondrial translocase
subunit. We demonstrate that Tim17b protein is required strictly for protein delivery to mitochondrial matrix. Knockdown of
Tim17b completely disrupts functions of the mitochondrial translocase complex. Using fluorescent recovery after
photobleaching assay, we show that Tim17b protein has a very stable localization in the membranes of the mitochondrial
network and that its exchange rate is close to zero when compared with soluble proteins of mitochondrial matrix. These
results confirm that we have developed comprehensive tools to study functions of heterochromatic Tim17b gene.
Citation: Garabedian M, Jarnik M, Kotova E, Tulin AV (2011) Generating a Knockdown Transgene against Drosophila Heterochromatic Tim17b Gene Encoding
Mitochondrial Translocase Subunit. PLoS ONE 6(10): e25945. doi:10.1371/journal.pone.0025945
Editor: Charalampos Babis Spilianakis, University of Crete, Greece
Received May 31, 2011; Accepted September 14, 2011; Published October 6, 2011
Copyright:  2011 Garabedian et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This research was supported by a grant from the National Institutes of Health (R01 GM077452) to AVT. The funders had no role in study design, data
collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Alexei.Tulin@fccc.edu
. These authors contributed equally to this work.
Introduction
Despite ongoing intensive research since the nineteenth century,
heterochromatin remains a mysterious domain of the genome. In
1933, Emil Heitz described distinct blocks of chromatin in the
nuclei of Drosophila cells that he termed ‘‘heterochromatin’’ [1].
Over the years, it has become clear that heterochromatin is a
ubiquitous component of all eukaryotic genomes [2], and, in some
cases, heterochromatic DNA encompasses up to 90% of the
genome. Genetic analysis and sequencing of heterochromatin have
shown that the major portion of heterochromatin consists of the
so-called satellite repeats [3,4,5] or tandem arrays that have a
specific short sequence ranging in length from two pairs to several
hundred pairs of nucleotides. Extensive circuits of such satellites
are located in centromeric regions. Moderate repeats are another
abundant class of elements that are also associated with
heterochromatin. This large subclass consists of mobile genetic
elements (ME) [6,7]. Besides satellite arrays and mobile elements,
heterochromatin contains ‘‘infrequent’’ unique genes [8], which
can be amplified and assembled into tandem arrays [9]. However,
the abundance of such repeated DNA and the ‘‘highly diluted’’
amount of unique sequences complicate standard structural and
genetic analysis of heterochromatin [10], making these areas of the
genome ‘‘terra incognita’’ for molecular genetics. Furthermore,
heterochromatin seems to have earned a reputation as ‘‘junk
genomic DNA’’ in the scientific community, thus making the study
of heterochromatin unpopular. Notwithstanding these drawbacks,
a growing body of evidence indicates that heterochromatin plays a
crucial role in a cell’s life cycle [11,12]. Heterochromatin contains
functional elements of chromosomes, centromeres, and telomeres
[13,14,15], as well as ribosomal DNA arrays [16]. Moreover, most
of the unique heterochromatic genes appear to be the housekeep-
ing genes [17,18]. Therefore, the study of heterochromatin,
though technically complicated, is important.
In Drosophila, heterochromatin takes up about 30% of the
genome [3,5] (Figure 1A). These genomic areas have suppressed
meiotic homology-dependent recombination [19,20]. Therefore,
homology-targeted mutagenesis [21] cannot be applied for
heterochromatic genes. The high level of dilution by repeated
DNA and transcriptional silencing within heterochromatin also
complicate standard random insertional mutagenesis [22,23].
Therefore, the most obvious method of targeting specific genes
within heterochromatin would use an RNAi knockdown strategy
[24,25].
In this study, we applied a snap-back transgenic RNAi approach
[24,25] to target a small heterochromatic gene, Tim17b, which is
located in constitutive heterochromatin of the third chromosome
near the previously characterized Parp1 locus (Figure 1B and C).
Tim17b is a typical heterochromatic locus located in a previously
well-characterized region [18], where unique exonic sequences are
separated by tandem arrays of repeated DNA (Figure 1C). Tim17b
is a relatively small locus which spans less than 5.5 kb of genomic
DNA, whereas exons take up only 0.5 kb, and promoter elements
characteristic of euchromatic genes are not detectable. Thus, it is
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[22,23] will ever target it. Tim17b encodes a mitochondrial
translocase subunit, which is involved in the delivery of proteins to
the mitochondrial matrix [26]. The Tim17b protein superfamily
demonstrates high evolutionary conservation in eukaryotes (Figure
S1A), suggesting that the functions performed by Tim17b in
mitochondria are also conserved and very important. In addition
to the Tim17b gene in heterochromatin of third chromosome, the
Drosophila genome contains two more Tim17b-like genes (Figure
S1B), CG1158 and CG15257, encoding Tim17b1 and Tim17b2
proteins and correspondingly localized in euchromatin of 3R and
2L chromosomal arms. However, we found that only Tim17b
expresses ubiquitously (Figure S1C), while the other two are
produced only in adult male tissues. Since Tim17b most likely
plays a major functional role in the translocase complex, we have
focused our research on this protein. Studies of mitochondria, in
general, and mitochondrial translocase complexes, in particular,
are very important because they allow us to understand the roles of
mitochondria in longevity, apoptosis, cellular senescence, and
tumorigenesis [27–30], as well as permit the development of new
therapeutic drugs. Therefore, the reagents and techniques
generated and characterized in this study will be useful for
analyzing mitochondrial function and regulation, as well as for
studying mechanisms of apoptosis.
Results
Tim17b-DsRed recombinant protein is localized to
mitochondria
Previously, we designed transgenic Drosophila expressing a
Tim17b-DsRed fluorescent reporter protein [18] (Figure 1D).
To analyze further Tim17b expression and protein localization,
Figure 1. Tim17b gene is located within constitutive heterochromatin of third chromosome. A. Schematic illustration of Drosophila
melanogaster chromosomes. Heterochromatic regions are shown in black. B. An ideogram of chromosome 3 heterochromatin. C. A scheme
summarizing the sequence organization around Tim17b locus. Retrotransposable and transposable repeated DNA are shown by black arrows
(arrowhead – 39 end). Genes identified by homology to known cDNAs are shown below (blue boxes correspond to exons). Distance to closest
characterized locus (Parp) is indicated. D. Generation of UAS-Tim17b-DsRed and UAS-Tim17b
RNAi transgenes. Structure of transgenic constructs is
shown. Nucleotide positions of Tim17b cDNA are indicated.
doi:10.1371/journal.pone.0025945.g001
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GAL4 drivers (described in Materials and Methods). We found
that Tim17b-DsRed was enriched in cytoplasmic network-like
structures in all Drosophila tissues tested in our experiments
(Figure 2A). The distribution of Tim17b-DsRed in the cytoplasm
precisely matches the localization of mitochondrial protein ATP-
synthase (Figure 2B), but it does not overlap with Golgi or
endoplasmic reticulum markers (Figure 2C and D). Flies
expressing Tim17b-DsRed are viable and do not exhibit any
defects in development or fertility. These results allow us to
conclude that our transgenic reporter Tim17b-DsRed has proper
localization in mitochondria and causes no disruptive effects on
mitochondrial functions. Therefore, the Tim17b-DsRed recombi-
nant protein should function properly as an in vivo marker of
mitochondrial translocase complex.
Co-expression of Tim17b-DsRed and Tim17b
RNAi
transgenes diminishes the amount of Tim17b-DsRed
protein and disrupts mitochondria
In order to disrupt Tim17b function, we employed a transgenic
RNAi strategy described in [31]. We cloned full-length 0.5 kb
Tim17b cDNA in direct and reverse orientation separated by
0.9 kb spacer DNA into pUASt vector (Figure 1D) and used this
Figure 2. Tim17b-DsRed recombinant protein is localized to mitochondria. A. Tim17b-DsRed (red) recombinant protein labels
mitochondria in all Drosophila tissues. MI – mid-intestine; BR – brain; SG – salivary glands; M – body wall muscles. DNA is stained with OliGreen dye
(green). B–D. Tim17b-DsRed recombinant protein is co-localized with mitochondrial protein ATP-synthase (B), but not with Golgi (C) or Endoplasmic
Reticulum (ER) (D) markers. The dissected larval salivary glands expressing Tim17b-DsRed (red) were stained with anti-ATP-synthase antibody (green)
and DNA binding dye Draq5 (blue) (B). The dissected larval salivary glands co-expressing Tim17b-DsRed (red) and CFP-Golgi (green) (C) or CFP-ER
(green) proteins (D) were stained with DNA binding dye Draq5 (blue).
doi:10.1371/journal.pone.0025945.g002
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protein is significantly diminished in animals co-expressing the
resultant Tim17b
RNAi transgene with Tim17b-DsRed when com-
pared with animals of the same developmental stage expressing
only Tim17b-DsRed (Figure 3A). Moreover, expression of intrinsic
Tim17b is also abolished by Tim17b
RNAi (Figure 3B). Most of the
animals expressing Tim17b
RNAi were arrested early in the
embryonic stage and died; less than 5% of the remaining embryos
survived up to later second-instar or third-instar. These results
confirm the effectiveness of the Tim17b
RNAi transgene. Therefore,
we tested further the effects of Tim17b
RNAi on mitochondria. We
dissected mid-intestine from Tim17b
RNAi–expressing surviving
second-instar larvae prior to lethal stage and examined these
tissues by transmission electron microscopy (TEM) analysis.
Strikingly, typical mitochondria (Figure 3C) were scarce in
Tim17b
RNAi-expressing cells. Instead, we often observed an
abnormal structure surrounded by double membrane with residual
cristae inside (Figure 3D). Moreover, we found that expression of
Tim17b
RNAi stimulates apoptosis (Figure 3E and F). These results
suggest that our Tim17b
RNAi transgene is effective in disrupting
mitochondrial function, thereby demonstrating, for the first time,
the essential role of the Tim17b protein in mitochondria.
Expression of Tim17b
RNAi transgene abolishes protein
delivery to mitochondrial matrix
According to previous studies, the Tim17b protein belongs to
the inner membrane translocase complex Tim23, which is
involved in the delivery of protein with specific cleavable N-
terminal peptide signal to the mitochondrial matrix and inner
membrane [26] (Figure 4A). Therefore, we tested whether the
expression of Tim17b
RNAi transgene would disrupt this pathway.
To track protein delivery into mitochondrial matrix, we used a
transgenic Drosophila expressing UAS::mito-GFP reporter [32].
This recombinant protein carries the N-terminal signal of
delivery into mitochondria [32]; upon expression in wild-type
Drosophila, it accumulates in mitochondria and co-localizes with
mitochondrial protein ATP-synthase (Figure 4B). However,
using inducible heat shock hs::GAL4 driver (see Materials and
Methods for details), co-expression of Tim17b
RNAi and mito-GFP
in third-instar larvae resulted in the accumulation of mito-
GFP in the cytosol, but not colocalization with ATP-synthase
(Figure 4C). ATP-synthase is a stable intrinsic transmembrane
mitochondrial protein expressed early during the larval devel-
opment. Therefore, when hs::GAL4 driver induces co-expression
of both Tim17b
RNAi and mito-GFP in third-instar larvae, ATP-
synthase is already localized properly inside the mitochondrial
membrane. While disruption of Tim17b protein production by
Tim17b
RNAi expression precludes mito-GFP delivery into mito-
chondria, the localization of ATP-synthase, which is expressed
earlier during the larval development, is not affected. Therefore,
even though expression of Tim17b
RNAi in third-instar larvae
blocks delivery of new mitochondrial proteins (mito-GFP), proper
localization of ATP-synthase demonstrates that the mitochon-
drial structure itself was not affected (Figure 4D and E). This
last finding suggests that expression of Tim17b
RNAi can allow
analyzing Tim23 translocase in a spatially and temporally
controlled manner, without broad cytotoxic effects.
Tim17b-DsRed fluorescent protein represents a useful
tool for the study of in vivo mitochondrial dynamics
The results described above indicate that the fluorescent
reporter protein Tim17b-DsRed and Tim17b
RNAi transgene are
sufficient for both the detection of translocase protein localization
Figure 3. Expression of Tim17b
RNAi transgene disrupts Tim17b
protein production. A. Co-expression of Tim17b-DsRed recombinant
protein with Tim17b
RNAi eliminates Tim17b-DsRed protein production.
Western blot hybridization was used to compare the amount of
Tim17b-DsRed protein in Gal4 69B; UAS-Tim17b-DsRed and Gal4 69B;
UAS-Tim17b-DsRed; UAS-Tim17b
RNAi larvae. Anti-Actin antibody was
used as a loading control. B. Expression of Tim17b
RNAi disrupts intrinsic
Tim17b mRNA production. RT-PCR using intrinsic Tim17b-specific
primers demonstrates that accumulation of Tim17b mRNA is abolished
in Tim17b
RNAi-expressing animals. The numbers 2 and 3 indicate age of
animals collected for analysis after egg laying. Primers specific to
Tubulin mRNA were used as a loading control. C–D. Expression of
Tim17b
RNAi disrupts mitochondria. The structure of wild-type mitochon-
dria detected by TEM (C) is affected in Tim17b
RNAi-expressing animals
(D). Arrows indicate mitochondria. E–F. Expression of Tim17b
RNAi
increases apoptosis in larval brain. WT – wild- type first-instar larvae
(E). Tim17b
RNAi-expressing first-instar larvae (F). Dissected larval brains
were stained using ApopTag (red), which detects apoptotic cells. DNA
visualized using OliGreen dye (blue).
doi:10.1371/journal.pone.0025945.g003
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organization and function of mitochondrial translocase complexes TOM, TIM9-10, TIM23 and TIM22. Arrow shows pathway of protein with cleavable
N-terminal signal translocation through TOM-TIM23 into matrix. Position of Tim17b protein (red) in TIM23 complex is shown. OM – outer membrane;
IMS – intermembrane space; IM – inner membrane. Green – protein of mitochondrial matrix. Blue – cleavable N-terminal signal peptide. B–C. Tim17 is
required for mito-GFP delivery to mitochondria. The dissected larval mid-intestine expressing mito-GFP (green) (B) or co-expressing mito-GFP (green)
with Tim17b
RNAi (C) were stained with anti-ATP-synthase antibody (red) and TOTO3 DNA binding dye (blue). Displacement of mito-GFP from
mitochondria is clearly seen in Tim17b
RNAi–expressing tissues. D–E. TEM analysis of tissues shown in B–C panels demonstrates that mitochondrial
structure has still not been compromised by the time mito-GPF delivery to mitochondria is disrupted. Red arrows indicate mitochondria.
doi:10.1371/journal.pone.0025945.g004
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tested the capability of Tim17b-DsRed reporter for in vivo assays.
In developing Drosophila, mitochondria have been studied
using immunohistochemical approaches [33], as well as GFP-
tagged reporters [32]. Here, we developed a method to visualize
live mitochondria using a red fluorescent reporter and high
resolution confocal microscopy. By visualizing mitochondria
within living tissue dissected from strains expressing Tim17b-
DsRed, we can study dynamic mitochondrial behavior. Time-
lapse confocal microscopy, as shown in Figure 5A, demonstrates
the ability to track the migration of a single mitochondria in the
cytoplasm of larval salivary glands. In many metabolically active
tissues, mitochondria form a network where individual mito-
chondria are interconnected [34]. In order to find these mega-
organelles, we examined live larval tissues expressing the
Tim17b-DsRed reporter. We found that cells of the larval
intestine contain such interconnected mitochondria (Figure 5B
and C). The interconnection of organelles to a single network
suggests the ability of individual mitochondria to exchange
soluble proteins of nucleoplasm. To test this hypothesis, we
employed the Fluorescence Recovery After Photobleaching
Assay (FRAP). We compared recovery rates for a soluble protein
of the mitochondrial matrix (mito-GFP) and the transmembrane
protein Tim17b-DsRed (Figure 6). Although mito-GFP rapidly
recovered after photobleaching in part of the mitochondrial
network (Figure 6B), Tim17b-DsRed protein showed almost no
recovery (Figure 6A). These results indicate that transmembrane
proteins of translocase complexes are stably positioned in the
individual mitochondrial unit and that the exchange rate for
these proteins is very low.
Figure 5. Use of Tim17b-DsRed fluorescent reporter for time-lapse microscopy of mitochondria, 3D reconstruction of
mitochondrial network and mitochondrial proteins dynamics assay. A. Time-lapse microscopy of live Drosophila tissue. Tim17b-DsRed is
shown in red color. DNA is detected using Draq5 dye (green). B–C. 3D-mitochondrial network within mid-intestinal cells. 1–9 represent individual
confocal sections. PR – X-Y projection. C. 3D reconstruction of the mitochondrial network is presented. Tim17b-DsRed is shown in red color. DNA is
detected using TOTO3 dye (green).
doi:10.1371/journal.pone.0025945.g005
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Heterochromatic regions comprise a considerable portion of
eukaryotic genomes. This compartment of the genome contains a
number of genetic loci that are just as important as euchromatic
genes [12,35,36], yet they are inaccessible for study by more
conventional methods. One of the hallmark features of hetero-
chromatic DNA is its strong enrichment in repetitive sequences.
This property of heterochromatin complicates further the
functional and structural analysis of heterochromatic loci. In
Drosophila melanogaster, approximately 30% of genomic sequences
are heterochromatic. Heterochromatin includes the entire Y-
chromosome and 50% of the X-chromosome, as well as 25% of
peri-centromeric chromatin of autosomes 2 and 3 (Figure 1A) [10].
With complete sequencing of the Drosophila genome, it has become
extremely important to develop and test strategies for targeting
specific genes located in heterochromatin. In this study, we
described the molecular genetics tools which target a small protein
encoding gene, Tim17b, located in centromeric heterochromatin of
the third chromosome.
Taken together, our findings demonstrate that an RNAi
knockdown strategy based on designing a snap-back transgene
can be successfully applied for targeting heterochromatic genes. By
ubiquitous expression of Tim17b
RNAi transgene, we were able to
disrupt mitochondria in an organism-wide manner (Figure 3),
using inducible driver functions of mitochondrial translocase
which could be affected at specific age-dependent developmental
stages (Figure 4). Collection of tissue-specific GAL4 drivers affords
the capability to express the UAS::Tim17b
RNAi transgene in specific
tissues or even in specific cells, thereby allowing the study of
mitochondrial function. Depletion of Tim17 protein by Tim17b
RNAi
transgene expression leads to lethality and apoptotic-like pheno-
Figure 6. Fluorescence Recovery After Photobleaching (FRAP) assay for Tim17b-DsRed and mito-GFP proteins. A. Tim17b-DsRed (red).
B. mito-GFP (green). White circle shows position of photobleached area (A–B). In contrast to soluble GFP protein of mitochondrial matrix, assay
demonstrates that Tim17b, which is a transmembrane protein, has a very slow replacement/dynamic rate (C).
doi:10.1371/journal.pone.0025945.g006
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RNAi
transgene with tissue-specific GAL4 drivers offers tools for
eliminating targeted cells. This technique may be useful in a wide
range ofstudies targetingdevelopment and organogenesis, as well as
mitochondrial biology.
Mitochondria contain highly complex translocase machinery
involved in the transport of proteins through the double
membrane bilayer. Metabolic and genetic disorders in mitochon-
drial structure and/or function have been linked to a number of
human diseases including cancer [27–29,37]. In fact, out of 4
million children born each year in the United States, 4000 develop
diseases which can be correlated with mitochondrial dysfunction
[27]. Cancerous cells, in particular, have been shown to have a
range of distinct defects in mitochondrial structure and metabo-
lism. Various cancer cell lines show major differences in terms of
the number, size, shape, and overall metabolism of mitochondria
[38,39,40]. Mitochondria found in rapidly growing tumors show a
tendency to present fewer and smaller mitochondria with fewer
cristae, suggesting a disruption in structure at the molecular level.
In fact, changes to the molecular structure of the mitochondrial
inner membrane have been found in cancer cell lines, including a
shortfall of ATPase components.
Although disruption of mitochondrial structure and metabolism
has been linked to cancer, no universal metabolic alteration
characteristic of all tumor lines has been identified in mitochondria
[27]. As demonstrated by TEM data, our RNAi knockout of the
Tim17b subunit of the Tim23 complex shows significant disruption
ofinnermembranestructure and cristaeformationofmitochondria.
In addition, this disruption completely eliminates protein transport
into the mitochondrial network. When combined with the red
fluorescent reporter transgene for Tim17b, this technique becomes
a highly useful tool for studying the Tim23 translocase complex
directly. We propose that this tool can be also applied for analysis of
mitochondrial metabolism in cancer cells, eventually leading to the
development of more targeted therapeutic treatments of cancer.
Materials and Methods
Drosophila strains and genetics
Flies were cultured on standard cornmeal-molasses-agar media
at 22–25uC. The fly stocks were generated by the standard genetic
methods or obtained from the Bloomington Drosophila Stock
Center, except as indicated. Genetic markers are described in
Flybase [41]. pP{w1, UAS::Tim17-DsRed}, called UAS:: Tim17-
DsRed, was described in [18]. pP{w1, UAS::mito-GFP}, called
mito-GFP, was described in [32]. The following GAL4 driver
strains were used: arm::GAL4 (Bloomington stock #1560), 69B-
GAL4 [42], and hs::Gal4, which was a gift from the G. Cavalli lab.
To induce expression from the hs::Gal4 driver, Drosophila larvae
were heat-shocked for 1 hr at 37uC twice daily for three days prior
to the late third-instar stage; then tissues were dissected for protein
localization and dynamics analysis.
Construction of transgenic Drosophila
To construct the anti-Tim17b RNAi transgene, we cloned a
693-bp fragment of Tim17b cDNA (from CK01513 clone) in
direct and inverted orientation within the pUASt vector. As a
spacer between inverted repeats, we used a 720-bp fragment of
DsRed sequence (Clontech) (Figure 1D). Transformation was as
described [43], with modifications [44].
Western blot
The following antibodies were used for immunoblotting assays:
anti-DsRed (rabbit, 1:1000, Clontech # 8370-1) and anti-Actin
(mouse, 1:1000, Chemicon). Western blotting was done using the
detection kit from Amersham/GE Healthcare (#RPN2106),
according to manufacturer’s instructions.
Electron microscopy (as described in [45]).
Immunostaining of Drosophila larval tissues
Larval tissues were dissected in Grace’s medium brought to
room temperature. Samples were then moved directly into fixative
solution of 4% formaldehyde in PBS containing 1% Triton X-100
(PBT) (in a 1.5 mL Eppendorf tube) and rotated at room
temperature for 30 minutes. After washing twice for 5 minutes
each in PBT, blocking solution of PBT containing 10% bovine
serum albumin (10% BSA) was applied to samples and rotated at
room temperature for 1 hour. Samples were washed in PBT
containing 1% bovine serum albumin (1% BSA) for 5 minutes.
Primary Rabbit anti-ATP-synthase antibody was then applied at a
dilution of 1:400. Samples were incubated in primary antibody
overnight at 4 degrees on nutator. After that, samples were washed
in PBT with 1% BSA solution three times for 10 minutes each.
Samples were incubated with appropriate secondary antibody at
room temperature on rotator for two hours. The following
secondary antibodies were used: Goat Anti-Rabbit Alexa 568,
Goat Anti-Rabbit Alexa 488 and Alexa 633 (from Molecular
Probes) at a dilution of 1:400. Next, samples were washed twice in
PBT buffer for 5 minutes and then subjected to chromatin staining
using Draq5 (Biostatus) at a dilution 1:500 in PBT buffer for
1 hour at room temperature on nutator or OliGreen (Invitrogen)
at a dilution of 1:10,000 in PBT buffer solution for 10 minutes at
room temperature. Samples stained with OliGreen were then
washed twice for 5 minutes in PBT buffer solution and fixed to
microscope slide. Images were obtained using the Leica (DM-IRB)
Confocal System.
Apoptosis detection
We used the ApopTagH Fluorescein In Situ Apoptosis Detection
Kit (Millipore # S7110) to detect the occurrence of cell death in
first instar larvae brains. Tissues from wild type or larvae
expressing Tim17b
RNAi were dissected in Grace’s, fixed as described
above, and washed 10 min in PBT. Tissues were processed
according to the manufacturer’s recommendations, then rinsed
with PBS, and immunostained as described above.
Imaging of Live Drosophila larval tissues, as described in
[32].
Fluorescence Recovery After Photobleaching (FRAP) assay
FRAP experiments on live Drosophila tissues were performed as
described in [46]. To conduct these experiments, we used a Leica
TCS SP2 confocal microscope with capacity for FRAP. To avoid
oxidative stress and other damage sometimes caused by lasers, we
used only the minimal level of laser power. This step extended the
‘‘bleaching’’ phase, but it did not affect our results. To collect
FRAP data, we employed the ‘‘FlyMode’’ program, which allows
data collection, even during the bleaching phase. Recordings were
performed via a 6361.4 NA oil immersion objective. Previously,
we found that all the fluorescent epitopes we tested (ECFP, EYFP
(Venus), EGFP, and DsRed) were appropriate for FRAP assays
[47], as well as for regular confocal analysis. We did not detect
epitope-specific biases in the function, expression dynamics or
localization of any fused moiety. We used transgenic fly stocks that
expressed appropriate fluorescent epitope-tagged protein. Tissues
were dissected in Grace’s Media, and dynamic movement of
fluorescent proteins was analyzed for 20–30 minutes following
dissection.
Mitochondrial Translocase Knockdown
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Figure S1 Evolutionary conservation for Tim17b pro-
tein in eukaryotes. A. Comparison of amino acid sequences of
Tim17 proteins from yeast (TIM17_YEAST), C. savinguvi (EN-
SCSAVT00000007450_CIOSA), D. persimilis (dper_GLEANR_
15855_ caf1_DROPE), C. briggsae (CBG01742_CAEBR), Rat
(Timm17b_predicted_RAT), Mouse (Timm17b_MOUSE), Bovine
(TI17B_BOVIN), Canis familiaris (TIMM17B_CANFA), Horse
(TIMM17B_HORSE), Human (TIMM17B_HUMAN), Chicken
(NP_001026197_CHICK) and D. melanogaster (gi|32330112|
gb|ADX35898.1). Evolutionary conservation and consensus se-
quence are shown below. B. Alignment of three Tim17b homo-
logues from Drosophila melanogaster genome: Tim17b (gi|323301112|
gb|ADX35898.1| MIP28909p); Tim17b1 (gi|24644195|ref|NP_
649526.2|); and Tim17b2 (gi|24584449|ref|NP_524746.2|). C.
Expression profiles of three Tim17b homologous proteins during
Drosophila development. RT-PCR using gene-specific primers
demonstrates that Tim17b1 and Tim17b2 express predominantly
in adult males, while Tim17b is ubiquitous in each tested
developmental stage. Primers specific to Tubulin mRNA were used
as a loading control.
(TIF)
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